SUP3R-1 ELITE by Olympus UK
1-Andro is a naturally occurring metabolite of DHEA in the human body. 1-Andro and its metabolites are incapable of aromatizing to estrogen, thus making it a very dry compound with no risk of bloat or dramatic negative effects on blood pressure.
Most notably 1-Andro is a non-methylated compound.
A paper published by West Texas A&M University, the California Baptist University and the University of Texas at Austin looked at the effects of 330mg free-form 1-Andro given daily for 4 weeks to 9 males with an average of 5 years of experience in resistance training and an average body fat of 13%. During the following 4 weeks, the subjects participated in 16 sessions of structured resistance-training. The results showed that the 9 males had gained an average of 10.4lbs (4.7kg) lean mass, lost over 4.4lbs (2kg) fat, and had a total load strength increase of 161lbs (73.2kg). No conflicts of interest, financial or otherwise, were declared by the author(s), and the research was supported by the West Texas A&M University Kilgore Research Center. Thus it can be extrapolated that this unbiased paper shows 1-Andro to be a highly effective compound and is capable of eliciting highly favorable changes in body composition.
Though 1-Andro has many beneficial effects, it is not without the possibility of side effects. On a positive note, 1-Andro is non-methylated (non-17a-alkylated) so there should be little to no concern regarding it negatively affecting the HDL/LDL ratio to the same extent other ph’s can. And since it does not aromatize to estrogen, estrogenic side effects such as water retention, bloating and gynecomastia should not be an issue. However some users experience lethargy and lower libido from 1-Andro, though this varies from person to person, with some experiencing little to no lethargy and others needing to lower their dosage or stop their cycle entirely. However, stacking with 4-Andro, Epi-andro or both typically mitigates any lethargy that might occur while using 1-Andro and keeps libido high as well. Other side effects such as oily skin, acne, reduced fertility or increased hair shedding are possible, though considered mild and temporary. It is possible that 1-Andro may cause some HPTA suppression, and therefore it is always recommended to run a properly planned Post-Cycle Therapy (PCT) following any supplementation regimen containing 1-Andro.
1-Andro is an excellent compound regardless of your goals; it can aid in gaining lean body mass and strength, or help maintain muscle and strength when dieting with a caloric deficit. It will stack well with almost any compound, for more dramatic gains in size and strength it is recommended to stack 1-Andro with an aromatizing compound such as 4-Andro, which will help mitigate any side effects regarding lethargy or low libido. Results generally take several weeks to manifest, but moderate gains of lean muscle mass and strength can be expected, though users should not expect rapid increases in size or weight due to extra-cellular and intra-cellular water retention being minimal to non-existent. This makes the gains from 1-Andro fairly easy to maintain post cycle.
So what do we know about 1-Androsterone?
•Non-Methylated/Non-Liver Toxic (Doesn’t require liver support such as TUDCA or NAC)
•Dry Compound/Non-Aromatizing (Won’t convert estrogen nor cause water retention or bloating)
•Increases Size/Muscle Mass (Increased Nitrogen Retention)
•Reduces Body Fat
•Excellent for Bulking/Recomping/Cutting
Though the risk of estrogenic side effects are essentially non-existant while on 1-Andro, we always recommended that you have an AI, such as AR1MACARE PRO, on hand.
1-Andro Example Cycles:
1-Andro – 220/220/220/220/220/220
*Space capsules out with meals containing fats.
1-Andro – 330/330/330/330/330/330/330/330
*Space capsules out with meals containing fats.
Post Cycle Therapy (PCT):
Olympus Labs Sup3r PCT (As indicated on label)
Our Andro Elite series utilizes S-SEDDS…what is this?
Self-emulsifying drug delivery systems (SEDDS). SEDDS have been proven in the last two decades to be a phenomenal success. They are able to overcome some of the biggest challenges confronting contemporary delivery science today by improving on the oral bioavailability of compounds with poor and inconsistent gastrointestinal absorption. SEDDS do so by facilitating absorption of compounds via the intestinal lymphatic system and thus circumnavigating the hepatic first-pass effect. The lymphatic system is a drainage network that extends throughout the entire body in proximity to the circulatory system and is a logical target since orally administered compounds can work more effectively when transported selectively to the intestinal lymphatic system. The bioavailability of compounds that undergo significant first-pass metabolism in the liver, as Andros do without enhanced delivery methods, can be improved dramatically by utilizing the lymphatic system for absorption in the intestine, thus avoiding the destructive first-pass effect in the liver.
However SEDDS are typically prepared in a liquid form, which can result in some disadvantages, for example, low stability, large volume of dose and issues with handling and portability. To overcome these issues, solid-SEDDS (S-SEDDS) has emerged to improve upon an already excellent delivery system. Through solidification of liquid self-emulsifying systems into powders the liquid SEDDS can be converted into solid dosage form without affecting compound release property. Thus, S-SEDDS combines the advantages of SEDDS (i.e., enhanced solubility and bioavailability) with those of solid dosage forms (e.g., high stability and reproducibility, compact dosage form and ease of handling and portability). Though it has little, if any, current presence in the world of supplementation, S-SEDDS is a cutting edge and highly effective delivery system utilized by the pharmaceutical industry. It is without a doubt one of the most effective means by which to deliver any compound at this point in time, and stands to replace other more antiquated methods delivery in the very near future.